Aortic Valve Replacement Devices Market To Hold a High Potential for Growth by 2025: Grand View Research Inc.

San Francisco, 25 January 2019: The Report Aortic Valve Replacement Devices Market Size, Share And Trends Analysis Report By Surgery (Open, Minimally Invasive), By Product (Transcatheter Aortic Valve, Sutureless Valve), By End-user, And Segment Forecasts, 2018 - 2025

The global aortic valve replacement market size is expected to reach USD 13.49 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 11.1% during the forecast period. Technological advancements in aortic valves and favorable reimbursement policies are boosting the growth of the market. Rising demand for minimally invasive surgeries is also triggering the growth of the market.

Widening base of geriatric population is one of the key growth stimulants. As per data published by Medicare and Medicaid services, the number of aortic stenosis patients over 65 years of age is constantly increasing in the U.S. Thus, rising incidence of aortic stenosis coupled with improving treatment rates is expected to bolster the growth of the market over the forecast period. In addition, growing preference for minimally invasive surgeries is escalating the growth of the market. These procedures cause lesser trauma to patient along with better outcomes and facilitate faster recovery than conventional open-heart surgeries. MIS requires relatively lesser number of hospital stays and is hence economically more viable than conventional invasive surgeries.

Favorable reimbursement policies are one of the crucial factors anticipated to drive the market in the near future. Centers for Medicare & Medicaid Services (CMS) announced that it would provide coverage for TAVR under the Medicare National Coverage Determination policy. Moreover, increasing number of clinical studies undertaken by key players for extending interventional scope, analyzing safety of devices, and assessing subsequent treatment alternatives is also working in favor of the market. However, product recalls due to safety concerns are projected to inhibit the growth of the market.

Access Research Report of Aortic Valve Replacement Devices Market @ www.grandviewresearch.com/industry-analysis/aortic-valve-replacement-devices-market

Further Key Findings From the Report Suggest:

·       Minimally invasive surgeries emerged as the leading surgery type owing to various advantages associated with them, such as limited trauma, quicker recovery, and cost-effectiveness

·       The transcatheter valve segment accounted for the largest revenue share in 2017 due to rising number of clinical studies for expanding their applications

·       In terms of end users, hospitals were the dominant revenue contributor in 2017 and ambulatory surgery centers (ASCs) are expected to exhibit remarkable CAGR over the forecast period

·       North America emerged as the largest regional market with a revenue share of 41.9% in 2017 and Asia Pacific is anticipated to post the highest CAGR over the forecast period

·       Themarket is highly fragmented in nature. Some of the prominent companies operating in the market are Edwards Lifesciences Corporation, Boston Scientific Corporation, St. Jude Medical, CryoLife, Medtronic, and LivoNova.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global aortic valve replacement market on the basis of surgery, product, end user, and region:

Aortic Valve Replacement Devices Surgery Outlook (Revenue, USD Million, 2014 - 2025)

·         Open surgery

·         Minimally invasive surgery

Aortic Valve Replacement Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Transcatheter aortic valve

·         Sutureless valve

·         Others

Aortic Valve Replacement Devices End-user Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Ambulatory surgery centers

·         Others

Aortic Valve Replacement Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Access Press Release of Aortic Valve Replacement Devices Market@ www.grandviewresearch.com/press-release/global-aortic-valve-replacement-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Calcined Anthracite Market to Raise at CAGR of 1.0% by 2025: Grand View Research Inc.

San Francisco, 25 January 2019: The Report Calcined Anthracite Market Size, Share & Trends Analysis Report By Technology (Gas, Electrical), By End Use (Pulverized Coal Injection, Basic Oxygen Steelmaking, Electric Arc Furnaces), And Segment Forecasts, 2018 - 2025

The global calcined anthracite market size is expected to reach USD 3.44 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 1.0% CAGR during the forecast period. High carbon content, along with superior thermal and electrical stability offered by the product as compared to conventional anthracite, is expected to propel its demand in steel manufacturing.

Calcined anthracite manufacturers position themselves in the market on the basis of product quality, price, and production volumes. However, persistent demand-supply gap in the industry, caused by declining raw material availability, coupled with presence of substitutes such as petcoke, is expected to limit industry growth.

Major manufacturers are primarily located in China, U.S., and European countries owing to easy access to anthracite in these regions. Many of these players have established contracts with anthracite mining companies to ensure secure flow of raw materials for manufacturing. However, declining mining activities across the globe are expected to hamper the raw material supply chain.

Discrepancies in production volume of anthracite coal have a severe impact on its pricing, which directly affects the prices of calcined anthracite. Anthracite prices have seen major fluctuations in the past five years owing to variations in mining output. Insufficient production volumes and rising raw material prices are likely to increase calcined anthracite prices in the near future.

Access Research Report of Calcined Anthracite Market @ www.grandviewresearch.com/industry-analysis/calcined-anthracite-market

Further key findings from the report suggest:

·       By technology, electrically calcined anthracite accounted for 74.8% of the overall volume in 2016 owing to its higher process efficiency

·       On the basis of end use, the basic oxygen steelmaking segment was valued at USD 642.1 million in 2016. The product offers a high carbon content relative to its cost and helps achieve up to 30% cost savings in steel manufacturing

·       China was the largest steel producer in the world in 2016, which also makes it the largest consumer of calcined anthracite in the world. That year, the country accounted for a share of 52.8% in the global demand

·       India is expected exhibit a revenue-based CAGR of 7.9% from 2017 to 2025 owing to rapid growth of the domestic steel manufacturing sector, coupled with recent ban on petcoke products in certain parts of the country

·       Insufficient production of calcined anthracite in comparison to its demand is expected to result in higher product prices over the forecast period, lowering the bargaining power of consumers

·       Calcined anthracite manufacturers differentiate their products on the basis of quality and price, keeping in mind properties such as carbon content and purity level

·       Key players such as Elkem Carbon, Rheinfelden Carbon, Resorbent s.r.o., and Asbury Carbons are mainly engaged in manufacturing electrical and gas calcined anthracite products specific to steel manufacturing applications.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/automotive-and-aerospace-interior-materials

Grand View Research has segmented the global calcined anthracite market on the basis of technology, end use, and region:

Calcined Anthracite Technology Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)

·         Gas Calcined Anthracite

·         Electrically Calcined Anthracite

Calcined Anthracite End-use Outlook (Volume, Kilotons, Revenue, USD Million, 2014 - 2025)

·         Pulverized Coal Injection (PCI)

·         Basic Oxygen Steelmaking

·         Electric Arc Furnaces

Calcined Anthracite Regional Outlook (Volume, Kilotons, Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Central & South America

·         Middle East & Africa

Access Press Release of Calcined Anthracite Market@ www.grandviewresearch.com/press-release/global-calcined-anthracite-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Varicose Vein Treatment Market Set to Witness an Uptick by 2024|Top Industry Leaders Medtronic plc, Dornier MedTech GmbH

San Francisco, 25 January 2019: The Report Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation (Laser Ablation, Radiofrequency Ablation), Stripping, And Segment Forecasts To 2024

The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market. 

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market. 

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.  

Access Research Report of Varicose Vein Treatment Market @ www.grandviewresearch.com/industry-analysis/varicose-vein-treatment-devices-market

Further key findings from the report suggest: 

·       In 2015, the sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.

·       The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.

·       In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.

·       In 2016, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region

·       As of 2016, Europe is characterized by a shift towards less-invasive procedures in treating large varicose veins. It is expected to witness a high growth rate over the forecast period due to the favorable government initiatives and advanced treatment procedures.

·       The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income

·       Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.

·       AngioDynamics, Inc. and MerzPharma GmbH & Co. KGaAin North America established a multi-year relationship to market Asclera for patients with peripheral vascular diseases.In the U.S,.MerzPharma GmbH & Co. KGaAserves as the exclusive distributor of the Asclera Injection. Asclera is approved for the treatment of spider and reticular veins, which showed good improvement in 95% of the patients treated with asclera.

·       In 2016, Medtronic plc acquired Italian hemodialysis player Bellco, Inc.This acquisition is projected to enable the medical device giant to gain market position in newly formed renal care solution business.

·       In 2015, Medtronic plc acquired Covidien plc with the objective to move into the additional therapeutic areas, such as chronic venous insufficiency. Covidien plc markets the Venefit procedure that uses radiofrequency energy and minimally invasive radiofrequency ablation to treat the disease. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global varicose vein treatment market on the basis of procedures, devices,and regions: 

Varicose Vein Treatment Outlook ByType (Revenue, USD Million, 2013 - 2024)

·         Sclerotherapy

·         Endovenous Ablation

·         Stripping

Varicose Vein Treatment Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Varicose Vein Treatment Market@ www.grandviewresearch.com/press-release/global-varicose-vein-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Care Management Solutions Market Size Is Expected To Reach USD 25.9 Billion by 2025| Key participants Koninklijke Philips N.V.

San Francisco, 25 January 2019: The Report Care Management Solutions Market Analysis Report By Mode of Delivery (Web, Cloud, On Premise), By Component (Software, Services), By End Use (Healthcare Providers & Payers), And Segment Forecasts, 2018 - 2025

The global care management solutions market size is expected to reach USD 25.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a 17.0% CAGR during the forecast period. Increase in adoption of technologically advanced solutions to reduce cost, paperwork, and duplication of testing, as well as improve safety and health are key factors fueling market growth. Rise in incidence of chronic diseases and growth in geriatric population are also factors likely to drive the market during the forecast period.

Care management solutions are likely to witness rapid growth in the coming years due to availability of funding and higher incidence of collaborations, mergers, and acquisitions. In May 2018, Allscripts announced the completion of its acquisition of HealthGrid Holding Company, a developer of enterprise patient engagement solutions. The acquisition signifies an expansion of the Allscripts FollowMyHealth platform, which provides patient engagement solutions focused on connecting consumers with providers.

Access Research Report of Care Management Solutions Market @ www.grandviewresearch.com/industry-analysis/care-management-solution-market

Further key findings from the report suggest:

·       Rise in incidence of chronic diseases, along with improved focus on healthcare quality services and development of innovative treatments and technologies, is expected to propel the market

·       By component, software accounted for the largest share in 2017. These solutions help provide coordinated and efficient care and aids providers in diagnosing patients effectively and reduce medical errors during surgery or clinical research.

·       On the basis of mode of delivery, cloud-based solutions are anticipated to exhibit the fastest growth over the forecast period. This is due to growing adoption of EHR by care providers to improve security, accessibility, and storage capability. Implementation of cloud-based solutions also leads to massive cost savings by providing healthcare through mobile devices and video conferencing

·       North America held the largest market share and is expected to retain its dominance over the forecast period due to advancements in IT solutions and increase in demand for affordable and scalable solutions in order to curb healthcare costs

·       Europe is likely to witness significant growth over the next decade due to adoption of advanced health informatics to make healthcare more patient-centric. Various government initiatives and ehealth investments are also expected to propel the regional market

·       Some of the key players in the market are Allscripts Healthcare Solutions, Inc.; Epic Systems Corporation; Cognizant; EXL; Koninklijke Philips N.V.; athenahealth, Inc.; Cerner; Medecision; and IBM.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the global care management solutions market based on component, mode of delivery, end use, and region:

Care Management Solutions Component Outlook (Revenue, USD Million, 2014 - 2025)

·         Software

·         Services

Care Management Solutions Mode of Delivery Outlook (Revenue, USD Million, 2014 - 2025)

·         Web-based

·         Cloud-based

·         On premise

Care Management Solutions End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Healthcare providers

·         Healthcare payers

·         Others

Care Management Solutions Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Access Press Release of Care Management Solutions Market@ www.grandviewresearch.com/press-release/global-care-management-solutions-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com